Evidence map›Paper›PMID 19878048›Full record

ArticleMolecular membrane biology2009

Endoplasmic reticulum-associated degradation of a degron-containing polytopic membrane protein.

Arpita Ray-Sinha, Benedict C S Cross, Aleksandr Mironov, Emmanuel Wiertz, Stephen High

Open access · bronzeAbstract read
In one paragraph

Article in Molecular membrane biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Ipomoeassin-F inhibits theJournal of cell science · 2021
    Article
  3. Ipomoeassin-F inhibits thebioRxiv : the preprint server for biology · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Arpita Ray-SinhaFaculty of Life Sciences, University of Manchester, Manchester, UK.
Benedict C S Cross
Aleksandr Mironov
Emmanuel Wiertz
Stephen High
University of Manchester · GBLeiden University Medical Center · NL

Funding

Biotechnology and Biological Sciences Research Council BB/G000948/1Medical Research Council G0501725Wellcome Trust 068848
6 · The paper itself

Abstract

The presence of two basic amino acids strategically located within a single spanning transmembrane region has previously been shown to act as a signal for the endoplasmic reticulum associated degradation (ERAD) of several polypeptides. In contrast, the functionality of this degron motif within the context of a polytopic membrane protein has not been established. Using opsin as a model system, we have investigated the consequences of inserting the degron motif in the first of its seven transmembrane (TM) spans. Whilst these basic residue reduce the binding of the targeting factor, signal recognition particle, to the first TM span, this has no effect on membrane integration in vitro or in vivo. This most likely reflects the presence of multiple TM spans that can act as targeting signals within in the nascent opsin chain. We find that the degron motif leads to the efficient retention of mutant opsin chains at the endoplasmic reticulum. The mutant opsin polypeptides are degraded via a proteasomal pathway that involves the actions of the E3 ubiquitin ligase HRD1. In contrast, wild-type opsin remains stable for a prolonged period even when artificially accumulated at the endoplasmic reticulum. We conclude that a single dibasic degron motif is sufficient to initiate both the ER retention and subsequent degradation of ospin via an ERAD pathway.

Indexed as

Amino Acid MotifsAnimalsCattleEndoplasmic ReticulumMembrane ProteinsMutagenesis, Site-DirectedOpsinsProteasome Endopeptidase ComplexProtein StabilityMembrane ProteinsOpsinsProteasome Endopeptidase Complex

Identifiers

PMID19878048
PMCPMC3428838
OpenAlexW1966874420

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.